Crescendo Biologics Competitors and Similar CompaniesClear all
Crescendo Biologics's competitors and similar companies include Celularity.
 Crescendo Biologics Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies. |  Celularity Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta. | |
Founding Date | Founding Date 2007 | Founding Date 2016 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Babraham, GB HQ | Locations Warren, US HQ Carlton, AU Madison, US |
Employees | Employees 12 | Employees 1932% increase |
Financial | ||
Revenue (est.) | Revenue (est.) £7.5m (FY, 2018) | Revenue (est.) $26.6m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $20.1m (FY, 2025) |
Gross profit | Gross profit £7.5m (FY, 2018) | Gross profit $6.5m (FY, 2025) |
Net income | Net income (£1.8m) (FY, 2018) | Net income ($91.7m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 116.2m | Total funding raised $ 290m |
For sources of this data, please see the company profile
View Company Profiles
Celularity
HQ
Warren, US
Employees
193↑ 2% increase
Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta.
View company